| 发明名称 |
BIOMARKERS FOR PREDICTING THE SENSITIVITY AND RESPONSE OF PROTEIN KINASE CK2-MEDIATED DISEASES TO CK2 INHIBITORS |
| 摘要 |
<p>Disclosed are biomarkers for determining the sensitivity of protein kinase CK2-mediated diseases, such as proliferative and/or inflammatory disorders, to treatment with CK2 inhibitors. These biomarkers can be used to predict or select subjects likely to be responsive to treatment with a CK2 inhibitor, and to treat or monitor subjects undergoing treatment with a CK2 inhibitor.</p> |
| 申请公布号 |
KR20120104196(A) |
申请公布日期 |
2012.09.20 |
| 申请号 |
KR20127011401 |
申请日期 |
2010.10.04 |
| 申请人 |
CYLENE PHARMACEUTICALS, INC. |
发明人 |
DRYGIN DENIS;O'BRIEN SEAN;ANDERES KENNA;VONHOFF DANIEL D.;LIM JOHN K. C.;PADGETT CLAIRE S.;BLIESATH JOSHUA R.;HO CAROLINE B.;RICE WILLIAM G.;SIDDIQUI JAIN ADAM |
| 分类号 |
G01N33/68;C12Q1/68;G01N33/574 |
主分类号 |
G01N33/68 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
